Clínica Médica
M-A | Eficácia de uma dieta restritiva na síndrome do intestino irritável.
4 Ago, 2022 | 14:05hComentário: Gluten-Free, Low FODMAP Diets Beneficial for IBS Symptoms – HCPLive
Conteúdos relacionados:
10 mistakes in dietary management of irritable bowel syndrome and how to avoid them.
Supplement: Irritable bowel syndrome and related conditions.
RCT: FODMAPs, but not gluten, elicit modest symptoms of irritable bowel syndrome.
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Guidelines for the treatment of irritable bowel syndrome
ACG Clinical Guideline: Management of irritable bowel syndrome
M-A: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome
Revisão | Tratamento da descompensação hepática na doença hepática avançada (comprometimento renal, insuficiência hepática, insuficiência suprarrenal e complicações cardiopulmonares).
4 Ago, 2022 | 14:02h
Revisão | Doenças que podem se apresentar de forma semelhante à dor ciática.
4 Ago, 2022 | 14:01h
Revisão | Manifestações cutâneas da lesão renal aguda.
4 Ago, 2022 | 14:00hCutaneous manifestations of acute kidney injury – Clinical Kidney Journal
Revisão | Tratamento da lesão renal aguda em pacientes oncológicos.
4 Ago, 2022 | 13:59hTreatment of acute kidney injury in cancer patients – Clinical Kidney Journal
Conteúdos relacionados:
Onconephrology: Update in Anticancer Drug-Related Nephrotoxicity – Nephron
Estudo randomizado | Gastroplastia endoscópica para tratamento de obesidade classes 1 e 2.
2 Ago, 2022 | 13:28hEndoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário no Twitter
MERIT trial suggests endoscopic sleeve gastroplasty should be considered as a synergistic weight loss intervention for patients with class 1 or class 2 obesity.
Find out more: https://t.co/FWeXeWbBF0 pic.twitter.com/W6qUKW92hR
— The Lancet (@TheLancet) July 30, 2022
Estudo randomizado | Intervenção com metotrexato em pacientes com artralgia sob risco de artrite reumatoide para reduzir o desenvolvimento da artrite persistente e o impacto da doença.
2 Ago, 2022 | 13:26hIntervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial – The Lancet (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Treatment before patients develop rheumatism provides lasting relief – Leiden University Medical Centre
Comentários no Twitter:
NEW in @TheLancet—The TREAT EARLIER trial shows that initiated in patients with arthralgia at risk of #rheumatoidarthritis did not prevent the development of clinical arthritis, but did modify the disease course https://t.co/5zh7lqb4NJ pic.twitter.com/lJflW9Prwm
— The Lancet Rheumatology (@TheLancetRheum) July 22, 2022
🆕🔥Methotrexate,🇳🇱study
MTX in pre-arthritis stage➡️ did not prevent the development of clinical arthritis
but ➡️sustained improvement in
♦️MRI-detected inflammation,
♦️Symptoms (Pain & EMS)
♦️Related impairments (HAQ n Presentism)
Vs placebohttps://t.co/I0IdKydPME pic.twitter.com/cNi6AhO151— EnvisionRheumat (@ERheumat) July 29, 2022
Breve revisão | Monitoramento da dor na unidade de terapia intensiva.
2 Ago, 2022 | 13:25hMonitoring pain in the intensive care unit (ICU) – Intensive Care Medicine (se o acesso a este link for pago, tente este)
Comentário no Twitter
Monitoring pain in #ICU
➡️ self‐assessment tools in pts able to self‐report
➡️ observational behavioural scales in pts unable to self‐report
➡️ physiologic parameters in pts unable to self‐report nor express behaviours (deep sedaution, NMBAs)#FOAMcc
🖇 https://t.co/SaD1BBxSNw pic.twitter.com/81tNNvnTDe— Intensive Care Medicine (@yourICM) July 30, 2022
Estudo de coorte | Intensidade da atividade física nos momentos de lazer e mortalidade por todas as causas e por causas específicas.
2 Ago, 2022 | 13:22hLong-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US Adults – Circulation (gratuito por tempo limitado)
Comunicado de imprensa: New study finds lowest risk of death was among adults who exercised 150-600 minutes/week – American Heart Association
Perspectiva | Aspirina para prevenção primária de doença cardiovascular aterosclerótica em mulheres.
2 Ago, 2022 | 13:20hAspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women – JAMA (gratuito por tempo limitado)


